In this issue:
Antibiotic use and IBD development
Pregnancy in women with IBD
Multiomic features associated with mucosal healing/inflammation in paediatric CD
Lymphoma with anti-TNF agents and/or thiopurines in IBD
Ustekinumab vs. vedolizumab after 1 year in anti-TNF-refractory CD
Outcomes of home infliximab infusions are suboptimal
Dietary inflammatory potential and IBD risk
IBD increases coeliac disease risk, and vice versa
Temporal trends in surgical resection rates and biologic prescribing in CD
Terminal ileum thickness during maintenance predicts response to infliximab for CD
Please login below to download this issue (PDF)